Medical cannabis,
legally prescribed

Clinic Director

‍

CEO

Gabriel is the CEO and co-founder of Cantourage UK. He has extensive experience in the technology industry and previously developed one of the UK's first functional CBD beverages.

His passion for cannabis stems from the medical benefits he witnessed first-hand in improving his brother's quality of life during a battle with cancer. He aims to make cannabinoid therapies widely available to suffering patients.

Consultant Psychiatrist | Clinical Lecturer

M.D., MA, MSc, BSc (Hons), MRCPsych, FHEADCP, MDCH, DCBH, PGCDM, PGCCE, MAcadMEd

Dr Mathew is a Community Psychiatrist in the NHS responsible for providing medical psychiatric support to a multi-disciplinary Primary Care Mental Health Service across East and North Kent.

Dr Mathew has extensive knowledge of mental health legislation having completed an MA in Medical Ethics and Law. He was appointed by the Ministry of Justice as a Medical Member of the First-tier Tribunal in the Social Entitlement Chamber. Dr Mathew also has a special interest in PTSD and Military Psychiatry having completed an MSc in War and Psychiatry and trained with the Royal Marines Reserve.

Dr Mathew was awarded Membership of the Academy of Medical Educators and Fellowship of the Higher Education Academy following his involvement in medical education which included being a University Lecturer.

As a Member of the Royal College of Psychiatrists Addictions Faculty, Dr Mathew has qualifications and expertise in the management of alcohol and drug misuse, particularly with co-morbid mental health problems. Due to his expertise, Dr Mathew is a Medical Examiner and Health Examiner for the General Medical Council.

Dr Mathew holds a Postgraduate Diploma in Rational Emotive Behavioural Therapy and he is also a qualified Medical Hypnotherapist. He incorporates a holistic approach in treatment that considers how biological, psychological and social factors impact on a person’s life and recovery journey. His work ethic has always been focused on trying to improve the outcomes of people with mental illness.

‍

Acute and Chronic Pain Management Consultant
‍

MBBS, FRCA, FFPMRCA
‍

Specialisms: Musculoskeletal pain; neuropathic pain; fibromyalgia; headaches; migraines; chronic neck, upper & lower back, shoulder, hip, knee, ankle pain; myofascial pain; inflammatory and connective tissue disorders; abdominal pain; pelvic pain; post-surgical pain and cancer pain.

Dr Sinovich qualified in anaesthesia and is professionally trained to treat different pain problems, particularly musculoskeletal pain and neuropathic pain. He is well renowned in his field following completion of specialised training in Pain Management at Guy's and St Thomas' Hospital, a world leading hospital in pain research and management.

Dr Sinovich is a pioneer in medical cannabis prescribing to chronic pain patients in the UK.  He has extensive experience in prescribing medicinal cannabis over the last 3 years with training undertaken in Canada. He has featured in cannabis health news, BBC news, and in the daily mirror on topics related to medicinal cannabis. He has presented various web-based seminars on medicinal cannabis to both patients and aspiring doctors wanting to enter the field of medicinal cannabis. He is involved in research trials to better understand the use of medicinal cannabis and making it more accessible to individuals with chronic pain.

Here are some interesting facts about Dr Sinovich:

• Granted Foundation Fellowship of the Faculty of Pain Medicine of the Royal College of Anaesthetists (FFPMRCA)
• Medical director of “Panacea Pain Relief Clinic” with consulting rooms at the Spire Clare Park Hospital, Frimley Park Hospital and Spire St Anthony Hospital
• Presented at numerous national anaesthesia and pain medicine conferences
• Member of the British Pain Society and of the European Society for Regional Anaesthesia & Pain Medicine
  
• Faculty member of the Royal College of Anaesthetists (RCA), the European Society of Anaesthesiology (ESA) and the Association of Anaesthetists (AAGBI)
• Local Pain Medicine Educational Supervisor responsible for teaching of undergraduate medical students in acute and chronic pain

‍

COO

Niall is the COO and co-founder of Cantourage UK, focused on developing strategic alliances for the European medical cannabis ecosystem. With a background in real estate investment and development, he is experienced in managing projects and building trusted relationships.

Niall is dedicated to supporting clinical research and promoting inclusive culture at Cantourage UK, with the goal of providing cost-effective and safe treatments for patients. He is committed to improving policy, regulation, and stigma around alternative therapies for a positive social impact.

CMO

Joshua is the CMO and co-founder of Cantourage UK. With a background in the Health and Wellness sector, he has a strong affinity for holistic treatments and has co-founded several cannabis start-ups to promote accessibility and awareness.

In early 2019, he was inspired by the benefits of medical cannabis during Gabriel’s brothers battle with cancer, which led him to team up with Gabriel, Niall, and Benjy to form NICE Partners with the goal of putting patients first.

Arjun is an efficient and conscientious patient coordinator with a background in oncology and haematology health care administration. He is dedicated to high-standard patient care and support at Cantourage Clinic.

Arjun's interest in cannabis-based medicine stems from researching alternative pain relief for a family member with Lyme disease. He believes in the effectiveness of alternative treatments.

Dahlia is a skilled professional with a passion for helping others. With a warm personality and a keen attention to detail, Dahlia has a natural ability to understand and respond to the needs of patients.

Whether answering questions, resolving issues, or simply providing a listening ear, Dahlia is dedicated to providing the highest level of care possible.

Co-CEO, Cantourage GmbH

Philip is joint chief executive officer of German cannabis company Cantourage GmbH, which he joined in April 2021. Under his tenure, Cantourage has developed and launched a disruptive platform. The solution helps non-EU cannabis producers to tackle the complexity of adhering to EU regulation, by easing market access and offering a completely new way of distributing their products to the European and UK medical markets.

Prior to this, Philip spent almost four years at Aurora Europe GmbH, initially as Director to build the European production and distribution network then taking on responsibility as Managing Director for the whole of Europe. Here Philip was responsible for driving and leading the company’s expansion in Europe. During his tenure at Aurora, he successfully established the company as market leader in dried flower products in multiple markets, as well as developing Aurora Deutschland which became the dominant force in the largest European medical cannabis market as well as the distribution and manufacturing hub to service all European medical markets.

Before Aurora, Philip led organizational and strategy development at undconsorten in Berlin, a management consulting firm founded and led by former McKinsey partners. He worked across business sectors mainly for DAX30 companies and developed everything from corporate visions and target operating models through to overarching change architectures.

He has a degree in industrial engineering from the University of Karlsruhe (Karlsruher Institut für Technologie) and in economics from the University of Sydney. During his studies, he was a scholarship holder of the “Studienstiftung des Deutschen Volkes”.

Founder, Cantourage GmbH

Florian founded German cannabis company Cantourage GmbH in September 2019 together with industry veterans, Patrick Hoffmann and Norman Ruchholtz. Since then, Cantourage has grown significantly and managed to achieve double-digit market share in the dronabinol segment in Europe.
‍
Prior to this, Florian was founder and CEO of Pedanios GmbH, the market dominating company for non-EU medical cannabis imports. He sold the company to Canada’s Aurora Cannabis Inc. in 2017, at which point Pedanios was the largest wholesaler in Europe with a market share of more than 75 per cent.
Before launching Pedanios, Florian spent six years in charge of solar panel producer Calyxo GmbH and four years as Chief Technology Officer of renewables company Q-Cells SE. He also spent six years as an engagement manager at glob-al consultancy McKinsey & Company in Munich.
‍
Florian started his career in the USA, working quantitative research in the capital markets division of First Union National Bank in North Carolina.
‍
Florian has PhD from Martin Luther University of Halle-Wittenberg in Saxony-Anhalt. He also has a degree in industrial engineering from the Karlsruhe Institute of Technology, completed his MBA at Charlotte in North Carolina and a degree from the University of California, Berkeley.

Founder, Cantourage GmbH

Patrick founded Cantourage GmbH, now a leading European cannabis company, together with industry experts, Dr Florian Holzapfel and Norman Ruchholtz, in September 2019.

Since its founding, Cantourage has actively established itself as a key player in all relevant medical cannabis segments and the price leader in the German Dronabinol market. The company is also revolutionizing the European medical cannabis market by operating a platform that helps non-EU producers to tackle the complexity of adhering to EU-GMP guidelines, significantly easing of market access and offering a completely new and enhanced way for them to distribute their products.

Before founding Cantourage, Patrick established Pedanios GmbH, Europe’s first wholesaler focusing on medicine for cannabinoid therapy, which he also started with Dr Holzapfel. Patrick was managing director for more than three years before selling the company to Aurora Cannabis Inc. of Canada in 2017, where he went on to become managing director for Germany. During his career in medical cannabis, Patrick has GMP-certified four cannabis facilities.

Prior to this, he spent a number of years working in account management for multinational telecommunications company Telefónica and at BEKO Käuferportal, Germany’s largest brokerage platform for capital goods and services. He also led SME sales for Vodafone in Germany between 2008 and 2011.

Patrick has an MA in political science from the Ludwig Maximilian University ofMunich (Ludwig-Maximilians Universität München).

Founder, Cantourage GmbH

Norman was one of the three founders of cannabis company Cantourage GmbH, which was established in 2019. Together with Dr Florian Holzapfel and Patrick Hoffmann, Norman launched the company with the vision of making cannabinoid therapies available and affordable in a variety of forms. Since its inception, Cantourage has already established itself as one of the leading European companies in the medical cannabis sector, with a unique business model that has enabled early profitability and immense growth and scaling potential.

Before founding Cantourage Norman established and led the Berlin-based German Institute for Medical Cannabis (Deutsches Institut für Medizinalcannabis). The institute was created in early 2018 as an independent research and educational institution to facilitate simple access for doctors and patients to the ever-growing body of scientific knowledge and practical experience in the burgeoning field of medical cannabis.

Prior to this, Norman developed his medical cannabis expertise between 2017and 2018 as an exclusive consultant to Aurora Deutschland GmbH, the German subsidiary of Canada’s Aurora Cannabis Inc., working in the spheres of expansion and location planning. During this period Norman was responsible for project management for tenders, notably leading the winning tender for Germany’sFederal Institute for Drugs and Medical Devices (BfArM), as a result of which Aurora was allocated five cultivation lots.

Norman also has deep experience and a proven track record in strategy consulting. Between 2009 and 2017 he served managing director of Riedel & Cie. Consulting, focusing on the areas of real estate project development, cash flow modelling and M&A due diligence. He also spent two years as a management consultant at KPMG AG, specializing in the area of mergers and acquisitions.

He studied business administration at Berlin’s University of Applied Sciences (Hochschule für Technik und Wirtschaft Berlin) and graduated 2007.